CASE STUDY

Post Views: 44
CASE STUDY Health Systems Oceania Surgery

CASE STUDY: Transforming surgical waitlist into a ‘preparation list’

By Bench Side Story — 6 days ago

The DIAMONDS initiative aims to transform the surgical waitlist into a “preparation list,” enabling healthcare professionals to optimise patient care in the months leading up to elective surgery starting at pre-admission phase.

Patients are will be able to complete pre-admission forms online, receive timely updates, and access educational resources to ensure thorough preparation. This will allow staff to spend more time with patients.

Post Views: 1,042
Cardiovascular CASE STUDY Europe Gastrointestinal Tract Hypertension Oceania

CASE STUDY Large scale genetic study finds link between Irritable Bowel Syndrome & cardiovascular system

By Bench Side Story — 8 months ago

Research published April 2024 in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD). 

Post Views: 825
Brain Cardiovascular CASE STUDY Dementia Hypertension Oceania Sleep

CASE STUDY High blood pressure and shorter sleep may worsen brain decline

By Bench Side Story — 8 months ago

People with high blood pressure who also lack sleep may be at increased risk of reduced cognitive performance and greater brain injury, Monash University research has found.

Published in the Journal of the American Heart Association, researchers assessed whether the combined effect of hypertension and short sleep duration had a negative impact on brain health.

Post Views: 978
CASE STUDY Leukaemia Oceania

CASE STUDY Link between levels of extracellular vesicles in the blood and tissue damage caused by diseases

By Bench Side Story — 10 months ago

A landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better detect the level of tissue damage in our bodies.

This study revealed, for the first time, a link between levels of EVs in the blood and tissue damage caused by diseases such as leukaemia.

Researchers hope to leverage the critical new insight to develop a blood test to monitor cancer patients with tissue damage, which could, in future, enhance treatment strategies for blood cancers and other diseases.

Post Views: 1,472
CASE STUDY Exercise Liver Oceania Policy and/or position statement

CASE STUDY Role of Exercise in Metabolic Associated Fatty Liver Disease

By Bench Side Story — 1 year ago

Dr. Shelley Keating AES AEP* is an Accredited Exercise Physiologist, a researcher, and a senior lecturer at the School of Human Movement and Nutrition Sciences at the University of Queensland in Brisbane, Australia. Dr. Keating’s research primarily focuses on the role of exercise in the management of metabolic dysfunction associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease. MASLD affects a significant portion of the global adult population, with many individuals unaware of their condition.

Post Views: 1,712
CASE STUDY Family Planning Medical Devices Oceania

CASE STUDY Next Generation Condom Contraception 

By Bench Side Story — 2 years ago

Eudaemon Technologies, an early-stage medtech company with a focus on sexual reproductive health, is developing a hydrogel condom to address the need for a better feeling, next generation condom, with the potential to improve user experience and address issues with traditional latex condoms.

“Over 1 million STI’s being diagnosed every day and up to 120 million unplanned pregnancies every year result in a $60 billion health burden across the globe”, says Co-Founder and Executive Director of Operations, Dr Simon Cook.

Formed in 2018, the company focuses on developing tough hydrogels as an alternative to address issues with odour, colour, and taste commonly associated with latex condoms. This technology can be loaded with small molecule drugs for flavours or anti-STI compounds, and was developed in response to a grant from the Bill and Melinda Gates Foundation to address unplanned pregnancies and STIs.

Post Views: 2,720
CASE STUDY Neonatal Oceania

Investigating the benefits of donor human milk for preterm infants

By Bench Side Story — 2 years ago

Together, SAHMRI and Lifeblood are leading a consortium to revolutionise the way human milk, and novel products made from human milk, are used as nutritional and medical interventions to improve health outcomes in vulnerable infants, but with potential application for a diverse range of medical indications.

Currently, babies who are born early preterm – before 32 weeks – are given donor milk when their own mother’s milk is not available or in short supply. Whether donor milk is beneficial for babies born just a few weeks early is unclear, as very little research has been undertaken with these babies.

The GIFT Trial will soon commence as an investigation between SAHMRI, the University of Adelaide, the Red Cross Lifeblood Milk Bank conducted at five sites across three states in Australia.

Post Views: 2,488
CASE STUDY Kidney Oceania

World-first clinical trial improves patient outcomes for kidney transplants (2023)

By Bench Side Story — 2 years ago

A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.

Around one in three people who receive a kidney transplant suffer delayed graft function, which means the transplant doesn’t work immediately and they require dialysis.

The lead-author of the study, was Royal Adelaide Hospital Nephrologist and University of Adelaide researcher, Dr Michael Collins.

Post Views: 1,968
Cancer CASE STUDY Gastrointestinal Tract North America Oceania Research

Engineering bacteria to detect colorectal cancer cells

By Bench Side Story — 2 years ago

An international team of researchers from Adelaide and the United States has engineered bacteria capable of detecting mutated DNA released from colorectal cancer cells, opening the door to faster disease detection.

Scroll to top